IL‐33 acts in a cell‐intrinsic manner to promote accumulation of ST2+ Tregs and prevent dysregulated intestine inflammation, while IL‐23 may disturb this homeostasis and contribute to IBD.54 This evidence concerns the gene IL33 and inflammatory bowel disease.